エネルギーに基づく治療市場：製品タイプ、臨床用途、エンドユーザー別-2025-2030年の世界予測

エネルギーに基づく治療市場の2023年の市場規模は68億米ドルで、2024年には72億8,000万米ドルに達すると予測され、CAGR 7.36％で成長し、2030年には111億9,000万米ドルに達すると予測されています。

エネルギーに基づく治療はヘルスケアの進化した分野であり、病状を治療するために様々な形態のエネルギーを利用し、従来の薬物療法に代わる治療法を提供します。この分野には、レーザー、高周波、超音波、マイクロ波などのエネルギーが含まれ、それぞれ組織の切除、治癒の促進、痛みや炎症の軽減などの治療効果を狙って標的組織に適用されます。エネルギーに基づく治療の必要性は、その低侵襲性にあり、従来の外科的手法に比べ、回復時間の短縮、感染リスクの低減、傷跡の軽減を可能にすることが多いです。これらの治療法は、皮膚科、腫瘍科、循環器科、整形外科など幅広い分野で応用されています。最終用途は、病院、専門クリニック、外来手術センターなど多岐にわたります。

市場の洞察によると、慢性疾患の有病率の上昇、技術の進歩、低侵襲処置に対する消費者の需要の増加が、この分野の成長に影響を与える主要促進要因であることが明らかになった。加えて、高齢化社会への人口動態のシフトは、加齢に関連する疾患がしばしば革新的な治療手法を必要とすることから、需要を促進しています。最新のビジネスチャンスとしては、新興市場におけるエネルギーに基づく治療の応用拡大が挙げられます。こうした機会を捉えるための提言としては、エネルギー技術の治療適応を広げるための研究開発への投資や、新興国市場への参入を促進するための戦略的パートナーシップの拡大などが挙げられます。

しかし、市場成長には、高い治療費、規制の壁、開業医や患者の限られた認識といった限界があります。課題には、有効性と安全性を実証するための厳格な臨床試験の必要性も含まれ、規制当局の承認や市場参入を遅らせる可能性があります。技術革新のための最良の分野としては、機器の携帯性とエネルギー効率の改善、複数のエネルギー様式を組み合わせて治療効果を高めるハイブリッド・システムの開発などが挙げられます。市場競争は激しいため、企業は継続的なイノベーション、戦略的提携、教育イニシアティブに注力し、障壁を克服して新たな動向を活用すべきです。

市場力学：急速に進化するエネルギーに基づく治療市場の主要市場インサイトを公開

エネルギーに基づく治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がんのような慢性疾患の罹患率の上昇と相まって、世界中で老年人口が増加しています。
  • 従来の手術や治療に対するマイクロ波焼灼システムの人気の急上昇。
• 市場抑制要因
  • 製品リコールの頻度の増加
• 市場機会
  • エネルギーに基づく治療の技術革新と開発
  • エネルギーに基づく治療に対する政府のイニシアチブと有利な償還政策
• 市場の課題
  • 認知度の低さ、熟練人材の不足、治療上の課題

ポーターのファイブフォース：エネルギーに基づく治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：エネルギーに基づく治療市場における外部からの影響の把握

外部マクロ環境要因は、エネルギーに基づく治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：エネルギーに基づく治療市場における競合情勢の把握

エネルギーに基づく治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス：エネルギーに基づく治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、エネルギーに基づく治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：エネルギーに基づく治療市場における成功への道筋を描く

エネルギーに基づく治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で高齢者人口が増加し、がんなどの慢性疾患の発症率も上昇しています。
    • 従来の手術や治療よりもマイクロ波アブレーションシステムの人気が高まっている
  • 抑制要因
    • 製品リコールの頻度の増加
  • 機会
    • エネルギーに基づく治療における技術革新と開発
    • エネルギーに基づく治療に関する政府の取り組みと有利な償還ポリシー
  • 課題
    • 認識と熟練した人材の不足と治療上の課題
• 市場セグメンテーション分析
  • 製品タイプ：深部病変の治療における温熱療法と超音波療法の利用増加
  • 臨床応用：エネルギーに基づく治療の美容応用への採用
  • エンドユーザー：エネルギーに基づく治療の専門クリニックの出現
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 エネルギーに基づく治療市場：製品タイプ別

• 凍結療法
• 油圧機械
• 電子レンジ
• 無線周波数
• 熱および超音波

第7章 エネルギーに基づく治療市場臨床応用別

• 美的
• 外科・眼科

第8章 エネルギーに基づく治療市場：エンドユーザー別

• クリニック
• 病院

第9章 南北アメリカのエネルギーに基づく治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のエネルギーに基づく治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのエネルギーに基づく治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ベアードメディカルのマイクロ波アブレーションシステムがFDA 510（k）認可を取得
  • OculusがIPL、高周波治療装置を発売
  • エンブレーション、中東で迅速なマイクロ波療法を開始
• 戦略分析と提言

企業一覧

• Alcon Vision LLC
• Alna-Medicalsystem AG
• AngioDynamics
• AtriCure, Inc.
• BIOLASE, Inc.
• Biolitec AG
• Boston Scientific Corporation
• Bovie Medical Corporation
• Candela Corporation by Syneron Medical Ltd.
• Cutera, Inc.
• Cynosure Inc.
• Dornier MedTech GmbH
• EDAP TMS S.A.
• Ellex Medical Lasers
• InSightec Ltd.
• IRIDEX Corporation
• Johnson and Johnson Vision Care Inc
• LightMed Corporation
• Lumenis Ltd.
• Medtronic plc
• NIDEk CO. LTD
• Optos plc
• PhotoMedex, Inc.
• Symmetry Surgical Inc.
• Ziemer Ophthalmic Systems AG

LIST OF FIGURES

• FIGURE 1. ENERGY-BASED THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. ENERGY-BASED THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ENERGY-BASED THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ENERGY-BASED THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HYDRO-MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY MICROWAVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY THERMAL & ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY SURGICAL & OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Energy-Based Therapeutics Market was valued at USD 6.80 billion in 2023, expected to reach USD 7.28 billion in 2024, and is projected to grow at a CAGR of 7.36%, to USD 11.19 billion by 2030.

Energy-based therapeutics is an evolving field within healthcare that harnesses various forms of energy to treat medical conditions, offering an alternative to traditional drug-based therapies. The scope of this field includes modalities like laser, radiofrequency, ultrasound, and microwave energy, each applied to target tissues for therapeutic effects such as tissue ablation, promotion of healing, or reduction of pain and inflammation. The necessity of energy-based therapeutics lies in its minimally invasive nature, which often enables quicker recovery times, reduced infection risks, and less scarring compared to traditional surgical techniques. These therapies have broad applications in dermatology, oncology, cardiology, and orthopedics. The end-use scope spans hospitals, specialty clinics, and ambulatory surgical centers.

Market insights reveal that the rising prevalence of chronic diseases, advancements in technology, and increasing consumer demand for minimally invasive procedures are key drivers influencing growth in this sector. Additionally, demographic shifts towards an aging population fuel demand, as age-related conditions often necessitate innovative treatment methodologies. The latest opportunities involve expanding applications of energy-based therapeutics in emerging markets, driven by increased healthcare spending and improved access to healthcare technology. Recommendations for capturing these opportunities include investing in research and development to broaden the therapeutic indications of energy technologies and expanding strategic partnerships to facilitate market entry in developing regions.

However, market growth faces limitations such as high procedural costs, regulatory barriers, and limited awareness among practitioners and patients. Challenges also include the need for rigorous clinical trials to demonstrate efficacy and safety, which can delay regulatory approvals and market entry. The best areas for innovation include improving device portability and energy efficiency and developing hybrid systems that combine multiple energy modalities for enhanced therapeutic outcomes. As the market nature is highly competitive, businesses should focus on continuous innovation, strategic collaborations, and educational initiatives to overcome barriers and capitalize on emerging trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Energy-Based Therapeutics Market

The Energy-Based Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
  • The surge in popularity of microwave ablation systems over conventional surgeries and treatment
• Market Restraints
  • Increasing frequency of product recalls
• Market Opportunities
  • Technological innovations and developments in energy-based therapeutics
  • Government initiatives and favorable reimbursement policies for energy-based therapeutics
• Market Challenges
  • The dearth of awareness and skilled manpower and therapeutic challenges

Porter's Five Forces: A Strategic Tool for Navigating the Energy-Based Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Energy-Based Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Energy-Based Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Energy-Based Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Energy-Based Therapeutics Market

A detailed market share analysis in the Energy-Based Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Energy-Based Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Energy-Based Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Energy-Based Therapeutics Market

A strategic analysis of the Energy-Based Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Energy-Based Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Alna-Medicalsystem AG, AngioDynamics, AtriCure, Inc., BIOLASE, Inc., Biolitec AG, Boston Scientific Corporation, Bovie Medical Corporation, Candela Corporation by Syneron Medical Ltd., Cutera, Inc., Cynosure Inc., Dornier MedTech GmbH, EDAP TMS S.A., Ellex Medical Lasers, InSightec Ltd., IRIDEX Corporation, Johnson and Johnson Vision Care Inc, LightMed Corporation, Lumenis Ltd., Medtronic plc, NIDEk CO. LTD, Optos plc, PhotoMedex, Inc., Symmetry Surgical Inc., and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Energy-Based Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Cryotherapy, Hydro-Mechanical, Microwave, Radiofrequency, and Thermal & Ultrasound.
• Based on Clinical Application, market is studied across Aesthetic and Surgical & Ophthalmic.
• Based on End-User, market is studied across Clinics and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
    • 5.1.1.2. The surge in popularity of microwave ablation systems over conventional surgeries and treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Increasing frequency of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovations and developments in energy-based therapeutics
    • 5.1.3.2. Government initiatives and favorable reimbursement policies for energy-based therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. The dearth of awareness and skilled manpower and therapeutic challenges
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Growing use of thermal & ultrasound energy-based therapeutics to treat deep-seated lesions
  • 5.2.2. Clinical Application: Adoption of energy-based therapeutics in aesthetic application
  • 5.2.3. End-User: Emergence of a specialized clinic for energy-based therapeutics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Energy-Based Therapeutics Market, by Product Type

• 6.1. Introduction
• 6.2. Cryotherapy
• 6.3. Hydro-Mechanical
• 6.4. Microwave
• 6.5. Radiofrequency
• 6.6. Thermal & Ultrasound

7. Energy-Based Therapeutics Market, by Clinical Application

• 7.1. Introduction
• 7.2. Aesthetic
• 7.3. Surgical & Ophthalmic

8. Energy-Based Therapeutics Market, by End-User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospital

9. Americas Energy-Based Therapeutics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Energy-Based Therapeutics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Energy-Based Therapeutics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Baird Medical's Microwave Ablation System Gains FDA 510(k) Clearance
  • 12.3.2. Oculus launches IPL, Radiofrequency Therapy Devices
  • 12.3.3. Emblation Launches Swift Microwave Therapy in the Middle East
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alcon Vision LLC
• 2. Alna-Medicalsystem AG
• 3. AngioDynamics
• 4. AtriCure, Inc.
• 5. BIOLASE, Inc.
• 6. Biolitec AG
• 7. Boston Scientific Corporation
• 8. Bovie Medical Corporation
• 9. Candela Corporation by Syneron Medical Ltd.
• 10. Cutera, Inc.
• 11. Cynosure Inc.
• 12. Dornier MedTech GmbH
• 13. EDAP TMS S.A.
• 14. Ellex Medical Lasers
• 15. InSightec Ltd.
• 16. IRIDEX Corporation
• 17. Johnson and Johnson Vision Care Inc
• 18. LightMed Corporation
• 19. Lumenis Ltd.
• 20. Medtronic plc
• 21. NIDEk CO. LTD
• 22. Optos plc
• 23. PhotoMedex, Inc.
• 24. Symmetry Surgical Inc.
• 25. Ziemer Ophthalmic Systems AG